Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SGEN | Common Stock | Award | $0 | +1.66K | +1.71% | $0.00 | 98.5K | Mar 13, 2023 | Direct | F1, F2 |
transaction | SGEN | Common Stock | Award | $0 | +3.32K | +3.27% | $0.00 | 105K | Apr 5, 2023 | Direct | F1, F2 |
transaction | SGEN | Common Stock | Sale | -$14.7K | -71 | -0.06% | $206.50 | 117K | Sep 21, 2023 | Direct | F3, F4 |
Id | Content |
---|---|
F1 | These shares represent restricted stock units and will be settled in common stock upon vesting. |
F2 | The performance criteria for these restricted stock units were met. These restricted stock units will become fully vested on 1/15/2024, subject to continuous service with the Company until the vesting date |
F3 | The sales reported in this Form 4 were effected pursuant to a written plan adopted on 11/4/2021 that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). |
F4 | Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. |